Tenaya Therapeutics, Inc. (NASDAQ:TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today
Shares of CommScope Holding Company, Inc. (NASDAQ: COMM) fell sharply during Monday’s session.
B of A Securities analyst Tal Liani downgraded CommScope from Neutral to Underperform and lowered the price target from $2.1 to $2.
CommScope shares dipped 6.9% to $2.2150 on Monday.
TN-301 First-in-Human Phase 1 Clinical Trial Results and Preclinical Combination Data to be Presented at Heart Failure Society of America Annual Scientific MeetingTN-201 Interim Seroprevalence Study Data and Phase 1b